While CRP has been evaluated as a triage/screening tool with mixed performance across populations and settings, its biologic responsiveness to treatment makes it attractive for short-horizon monitoring once TB is diagnosed or strongly suspected [9,10,11,12,13,14]. This evidence concerns the gene CRP and tuberculosis.